Ocata Therapeutics (OCAT) Reports Q3 Loss Per Share of $0.09

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. SPY
7. CVS
8. UNH
9. DAL
10. TMUS

Go back to Ocata Therapeutics (OCAT) Reports Q3 Loss Per Share of $0.09

Ocata Therapeutics to Host Conference Call and Webcast to Provide Corporate Update for the Third Quarter of 2015

November 6, 2015 3:30 PM EST

Call Scheduled for Monday, November 9, 2015 at 8:30 A.M.

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Ocata Therapeutics, Inc. (NASDAQ: OCAT), a leader in the field of Regenerative Ophthalmology announced today that it will host a conference call on Monday, November 9th, 2015 at 8:30 a.m. EST, during which it will provide a corporate update for the third quarter of 2015.

Interested parties may access the call live by dialing (888) 539-3679 (US) or (719) 325-2370 (international) and using conference ID 1107447.

A live audio webcast of the presentation will be available via the... More